Sectors
TLX
Telix Pharmaceuticals Limited
10.36
4 x 10.35
3 x 10.36
bid
ask
-
0.56
5.17%
01:55 PM
timesize
| Ytd | 38.25% | |
| 1y | -36.39% |
10.33
day range
10.57
6.28
52 week range
16.94
| Open | 10.49 | Prev Close | 10.92 | Low | 10.33 | High | 10.57 | Mkt Cap | 3.70B |
| Vol | 142.61K | Avg Vol | 165.46K | EPS | -0.02 | P/E | -593.48 | Forward P/E | 2500.00 |
| Beta | -0.31 | Short Ratio | 1.08 | Inst. Own | 0.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-25 | 50-d Avg | 10.37 | 200-d Avg | 9.30 | 1yr Est | 20.98 |
| Income Statement | |||
| Weighted Average Shares | 334.72M | ||
| Balance Sheet | |||
| Cash and Equivalents | 141.87M | ||
| Cash and Equivalents (USD) | 95.21M | ||
| Investments | 37.09M | ||
| Investments Non-Current | 37.09M | ||
| Trade and Non-Trade Receivables | 129.20M | ||
| Current Assets | 330.28M | ||
| Property, Plant & Equipment Net | 115.61M | ||
| Total Assets | 1.16B | ||
| Debt Current | 18.66M | ||
| Total Debt | 467.11M | ||
| Current Liabilities | 231.62M | ||
| Debt Non-Current | 448.45M | ||
| Total Liabilities | 748.61M | ||
| Accumulated Retained Earnings (Deficit) | -154.54M | ||
| Shareholders Equity | 415.38M | ||
| Shareholders Equity (USD) | 278.78M | ||
| Assets Non-Current | 833.71M | ||
| Total Debt (USD) | 313.49M | ||
| Deferred Revenue | 402.00K | ||
| Goodwill and Intangible Assets | 592.82M | ||
| Inventory | 37.08M | ||
| Liabilities Non-Current | 516.99M | ||
| Trade and Non-Trade Payables | 150.35M | ||
| Tax Assets | 65.40M | ||
| Tax Liabilities | 75.45M | ||